Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Researchers unveiled the Automated Cell Culture Splitter, an open‑source system built around the Opentrons OT‑2 robot and a custom cell‑counting imager. In tests with HEK293T cells, the platform cut hands‑on passaging time by 61% and delivered a 92% usable imaging site rate, far surpassing the 52% achieved manually. The design costs roughly $18,000, making high‑throughput cell‑culture automation accessible to typical research labs. By standardizing seeding, the system promises greater experimental reproducibility and reduced ergonomic strain for scientists.
Sanofi’s BTK inhibitor tolebrutinib failed pivotal late‑stage trials in both relapsing and primary progressive multiple sclerosis, prompting the FDA to reject its approval over liver toxicity concerns. The setback highlights the challenges of BTK‑targeted therapies, even as competitors like Roche’s...
Pharma companies are curbing investment amid pricing pressure and growth anxiety, creating a self‑fulfilling slowdown. To protect against supply disruptions, firms are auditing entire supply chains, adding second and third sources, and holding safety stock, which ties up cash. Geographic...
Addgene, celebrating two decades of plasmid distribution, now offers nearly 10,000 unique research tools to industry scientists. The collection spans fluorescent protein plasmids, AI‑generated CRISPR editors, enzyme‑producing vectors, viral‑vector kits, and extensive antibody libraries. New filters on the Addgene website...
There hasn't been a report of a dairy herd infected with #H5N1 #birdflu in the past 30 days. Does that mean there've been no infected herds? Or no reported herds? 🤷♀️ Since the virus was first discovered to have moved into...
The Netherlands hosts a dense biotech ecosystem anchored by hubs such as Leiden Bio Science Park, which supports over 400 firms and 25,000 jobs. Seven standout companies illustrate the country’s breadth, from Leyden Labs’ intranasal antibody sprays to Merus’ bispecific...
Sarepta Therapeutics is shifting focus from a troubled DMD gene‑therapy portfolio to a robust siRNA pipeline partnered with Arrowhead. Jefferies highlights upcoming Phase I/II data for SRP‑1001 (FSHD) and SRP‑1003 (DM1) in Q1 2026, projecting a potential 25‑50% stock move. The...
Artificial intelligence platforms are now integrating multimodal imaging, genomics, and clinical data to improve glioma diagnosis and personalize treatment plans. Recent trials show AI‑driven segmentation reduces radiologist workload by 40% and predicts tumor grade with 92% accuracy. Companies such as...
The U.S. Food and Drug Administration has lifted the partial clinical hold on Merck and Daiichi Sankyo’s antibody‑drug conjugate ifinatamab deruxtecan (I‑DXd) in the Phase III IDeate‑Lung02 trial for relapsed small‑cell lung cancer. The companies can now resume enrollment and data...
Marea Therapeutics announced that its experimental drug for acromegaly has entered Phase 2 clinical testing. The move follows CEO Josh Lehrer’s October 2023 appointment and a review that revealed the compound had not met earlier expectations in pre‑clinical models. The Phase 2...
👀 Real precision medicine from $AZN $DSNKY TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer “…TROPION-Lung17 is the first phase 3 clinical trial to prospectively enroll patients with tumors...
Total body MRI scans generate lots of false positive results. Then there's the false negatives, too. https://t.co/7NITyu2sqM @PeterWhoriskey https://t.co/PW1Q2XjOn4
Superorganism, launched in 2023, closed its inaugural fund with $25.9 million from investors including the Cisco Foundation and Andreessen Horowitz partner Jeff Jordan. The firm will write $250,000‑$500,000 checks for pre‑seed and seed‑stage biodiversity startups and donate 10 % of profits to...
Genome editing for treatment of diseases has been constrained to blood, liver and eye targets due to delivery obstacles. But that's about to change. a @NatureBiotech review https://t.co/NJHiMlHMVY https://t.co/pFDftgEWRX
From our STAT #JPM26 event last night: Pazdur warns that politics, ‘chaos’ are damaging FDA Veteran drug regulator, who left the agency last month, says industry hasn’t fully realized extent of the issues https://t.co/ewSxWBoKGl via @elaineywchen
A 2026 Pediatric Research study by Saad et al. merges worldwide epidemiological data with molecular profiling to map Autism Spectrum Disorder’s (ASD) prevalence, risk factors, and economic impact. The analysis reveals a global prevalence of roughly 1.2%, with marked regional...
1/@BeamTx’s #JPM26 excellent presentation emphasised its strategic priorities & future milestones for 2026. Here’s my🧵👇which elaborates on BEAM’s current pipeline, the regulatory breakthroughs that $BEAM has managed to negotiate with the FDA & its corporate status $XBI #JPM2026 https://t.co/kK7Q1YVjOV
Novartis has agreed to pay $50 million upfront to license a peptide‑based radiopharmaceutical asset from China’s Zonsen PepLib Biotech. The agreement, announced Monday, adds a novel imaging candidate to Novartis’ growing portfolio of radiopharma programs. Zonsen PepLib, a biotech focused on...
Amgen announced on day two of the J.P. Morgan Healthcare Conference that its experimental long‑acting obesity injection, Maritide, met primary endpoints in a Phase 2 trial. The data showed statistically significant weight loss and favorable safety signals in patients with obesity....
AbbVie has signed a most‑favoured‑nation pricing deal with the Trump administration, committing $100 billion to U.S. research, development and manufacturing over the next ten years. The agreement mirrors those of 16 other large pharma firms and secures an exemption from potential...
Researchers identified plasma extracellular vesicle (EV) LINE‑1 RNA as a potent systemic aging factor that rises sharply with age and correlates with brain‑aging biomarkers. In mouse models, aged EVs cross the blood‑brain barrier, deliver LINE‑1 RNA to microglia, and activate...
Creating bacterial genomic diversity through large-scale reconfigurations reveals phenotype robustness to organizational genome change https://t.co/TiY6WNWjUm
Researchers highlight a bidirectional link between the aging gut microbiome and skeletal muscle, where myokine signaling shapes microbial composition and microbial metabolites influence muscle mass. Dysbiosis and reduced myokine secretion create a vicious cycle that accelerates sarcopenia. Interventions that modulate...
Sentynl Therapeutics announced that the U.S. Food and Drug Administration has granted approval for its investigational therapy targeting Menkes disease, a rare and fatal genetic disorder of copper absorption. The approved product, branded Zycu..., is the first therapy in the...
New research shows that maternal vitamin K consumption during pregnancy significantly influences early brain development in offspring. The study, involving longitudinal imaging and cognitive testing of 1,200 infants, found higher maternal K intake associated with increased myelination and better neurocognitive...
The UK medicines regulator reported a 9% rise in clinical trial applications year‑over‑year, with early‑stage studies leading the growth. Healthy‑volunteer and first‑in‑human trials increased 16% and 5% respectively, while sponsor requests for regulatory advice surged 75%. The MHRA announced a...
Tufts University's Center for Cellular Agriculture (TUCCA) and the Good Food Institute have purchased eight cultivated‑beef cell lines and serum‑free media from the defunct SciFi Foods. The assets, including CRISPR‑edited lines capable of indefinite growth in single‑cell suspension, will be...
Researchers have identified that extracellular lactate activates the GPR81 receptor, which in turn engages the FARP1 signaling cascade to promote glucose uptake without insulin. The study demonstrated a 30% increase in glucose transport in muscle cells and a 20% boost...
Sonoma BioTherapeutics, a T‑regulatory cell biotech based in Sonoma, announced a workforce reduction across its Seattle, South San Francisco and remote positions following the appointment of a new chief executive officer. The cuts affect multiple departments as the company seeks...
Merck completed its cash tender offer to acquire Cidara Therapeutics, paying $221.50 per share. The offer was accepted for 27.15 million shares, representing about 86% of Cidara’s outstanding stock, and will be finalized through a merger making Cidara a wholly‑owned subsidiary....
Researchers have demonstrated that the natural compound carvacrol and the antimalarial drug chloroquine work synergistically to trigger apoptosis in metastatic melanoma cells. In vitro experiments showed markedly higher cell death when both agents were combined than when used alone, and...
The National Security Commission on Emerging Biotechnology released a report urging the FDA to modernize its policies as biotech innovation outpaces regulation. The document proposes nearly two dozen specific reforms aimed at accelerating approvals while preserving safety. Recommendations include real‑time...
Big‑pharma leaders including AbbVie, Amgen and Eli Lilly urged the FDA to decouple pre‑approval inspections from marketing applications and modernize its post‑approval change framework. They argue the 1990s SUPAC guidance treats all biologics as high‑risk, slowing domestic facility transfers. The coalition...
Good dialog - worth the 3.5min listen 👂 TLDR - investors do not like uncertainty. Macro uncertainty, technical uncertainty, commercial uncertainty. Remove uncertainty and number go up $XBI
A 17-year-old built a mind-controlled prosthetic arm using #AI via @Khulood_Almani #Technology #Innovation #EmergingTech #TechForGood https://t.co/A0Aib1IG5I
At JPM26, life‑science investors and policymakers dissected the Trump administration’s disruptive biotech agenda. Health Secretary Robert F. Kennedy Jr. ordered the CDC to drop several childhood‑vaccine recommendations, unsettling billion‑dollar vaccine revenues. The administration’s focus on Most Favored Nation (MFN) drug‑pricing leverage spurred a...
Dozens of biotech firms and investors announced senior‑level moves ahead of the J.P. Morgan Healthcare Conference, with several companies naming new CEOs. At Argenx, co‑founder Tim Van Hauwermeiren is stepping down after 18 years to become chairman, while COO Karen Massey, a...
Researchers at Japan’s National Institutes for Quantum Science and Technology combined adaptive laboratory evolution with repeated gamma‑ray mutagenesis to create heat‑tolerant Bradyrhizobium diazoefficiens strains. By exposing cultures to stepwise temperature increases and ten 40 Gy irradiation rounds, they reduced development time...
Mirador Therapeutics announced a $120 million Series B round, while KinaseT secured $95 million in a Series A financing. Both rounds were led by top‑tier biotech investors including OrbiMed, ARCH Venture Partners and Sofinnova Partners. The capital will accelerate the companies' oncology and immunotherapy...
AbbVie announced a $5.6 billion agreement with RemeGen to acquire rights to a bispecific antibody that simultaneously blocks PD‑1 and VEGF. The deal, disclosed at JPMorgan’s Day 1 event, provides RemeGen with a substantial upfront payment and ties future milestones to clinical...
Trenchant Biosystems unveiled data from its AutoCell CGT manufacturing prototype, claiming a reduction of vein‑to‑vein timelines from six weeks to just 2.5 days. The platform reportedly delivers a seven‑fold increase in gene‑modified cell yield while cutting costs by up to...
Apuri, a new Shanghai‑based early‑stage venture firm, is launching its debut fund to commercialize biotech breakthroughs emerging from China’s academic labs. The firm is founded by three seasoned entrepreneurs whose backgrounds span biotech executive leadership, investment banking and venture capital....
Researchers at HKUST have unveiled an automated robotic nanoprobe that can locate and extract a single mitochondrion from a living cell without fluorescent labels. The device integrates nanoelectrodes that sense ROS/RNS bursts and dielectrophoretic nanotweezers that capture the organelle within...
A team led by Prof. Martin Grininger at Goethe University engineered a fatty‑acid synthase (FAS) enzyme that lets yeast synthesize custom short‑chain fatty acids, demonstrated with a 12‑carbon product normally sourced from palm or coconut oil. By swapping a single...
Pretzel Therapeutics announced the acquisition of Rome Therapeutics, a company specializing in “dark genome” research. The deal brings Rome’s functional genomics platform, extensive data sets, and scientific team under Pretzel’s AI‑driven drug discovery umbrella. Financial terms were not disclosed, but...
On Day 1 of #JPM26, no blockbuster headlines, but biotech newsmakers still move markets https://t.co/3cVFMwFBiI
Basecamp Research, in partnership with Nvidia, unveiled a gene‑editing toolkit built from AI‑generated enzymes. The startup leveraged evolutionary deep‑learning models running on Nvidia GPUs to design proteins that insert DNA sequences with unprecedented precision. Early laboratory data indicate higher on‑target...
Novo Nordisk CEO Mike Doustad highlighted the explosive growth of telehealth‑driven GLP‑1 obesity drug sales. He noted that compounding pharmacies have rapidly scaled to meet demand, creating a new distribution model. Doustad argued that traditional pharma can learn from this...
Reporting from inside the room... With a grin — and tight lips — Revolution Medicines’ $RVMD CEO faces questions about acquisition https://t.co/75ftdUF2Jh #JPM26
Researchers have deployed wearable sensors to continuously monitor daily mobility in patients with atypical Parkinsonian disorders. The study captured granular gait, step count, and activity‑level data over several weeks, revealing distinct movement signatures across disease subtypes. Findings show that reduced...
